GSK-Partnered Alector Hit By Renewed Dementia Skepticism

Doubts About Biomarker

 
• By Andrew McConaghie
  
Brain research
New investment is flooding into neuroscience, but understanding of disease mechanisms still lags far behind areas such as oncology and cardiovascular disease
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip